Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Biotalys NV ( (DE:86C) ) has shared an update.
Biotalys has received a positive recommendation from the Dutch regulatory authority CTGB for the approval of its biofungicide EVOCA in the European Union, marking a significant milestone for the company. This recommendation highlights the promise of Biotalys’ innovative AGROBODY™ technology and could strengthen its position in the AgTech sector, although further regulatory steps in Europe and ongoing reviews in the United States remain before full market approval can be achieved.
More about Biotalys NV
Biotalys is an Agricultural Technology company focused on developing protein-based biocontrol solutions to offer sustainable alternatives to traditional chemical pesticides. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), it is based in Ghent, Belgium, and listed on Euronext Brussels since July 2021. The company leverages its AGROBODY™ technology platform to create a diverse product pipeline aimed at enhancing crop protection across the agricultural value chain.
YTD Price Performance: 5.23%
Average Trading Volume: 741
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €129.2M
See more insights into 86C stock on TipRanks’ Stock Analysis page.
